HIGHFDA DRUG

HANDELNINE GLOBAL Recalls Rheumacare Capsules Due to Lead Risk

HANDELNINE GLOBAL recalled Rheumacare capsules on December 22, 2025, after discovering lead contamination. The recall affects four bottles of 30 capsules each distributed in New York. Consumers should stop using the product immediately and contact their healthcare provider.

Official notice
HANDELNINE GLOBALHealth & Personal CareDrugs & MedicationsLot: CAM040Exp. 06/30/2029 Lot: CAL079-NExp. 09/30/2028

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
December 22, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 22, 2025
Hazard Level
HIGH
Brand
HANDELNINE GLOBAL
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
HANDELNINE GLOBAL
Product type
Rheumacare Capsules
Model numbers
Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Sold at
Unknown
Where affected
NY

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 22, 2025

  2. Reported by FDA DRUG

    February 11, 2026

  3. RecallRadar source check

    February 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: product found to contain lead.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact HANDELNINE GLOBAL LLC or your healthcare provider for guidance. Notification method: Press Release

About This Product

Rheumacare capsules are marketed as dietary supplements for joint pain relief. Consumers often buy them for managing arthritis and other inflammatory conditions.

Why This Is Dangerous

The presence of lead in the capsules presents a significant health risk. Lead is a toxic metal that can cause serious health issues, particularly affecting the nervous system and various bodily functions.

Industry Context

This recall is not part of a broader industry pattern.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the bottle: CAM040, CAL079-N, or the expiration date of 09/30/2028.
  2. If your lot number matches, stop using the product immediately.
  3. Contact the distributor for further guidance.

Where to find product info

The lot number and expiration date can typically be found on the label or bottom of the bottle.

What timeline to expect

Expect a refund or guidance within 4-6 weeks after contacting the distributor.

If the manufacturer is unresponsive

  • Document all communication attempts with the distributor.
  • Consider filing a complaint with the FDA if no response is received.

How to prevent similar issues

  • Always check for recalls before purchasing dietary supplements.
  • Look for products with verified safety certifications.

Documentation advice

Keep a record of your purchase, including receipts and any correspondence with the distributor.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves Rheumacare capsules, sold in 30-count bottles. The affected lots include CAM040, CAL079-N (exp. 06/30/2029), and another with an expiration of 09/30/2028.

Key Facts

  • Recalled on December 22, 2025
  • Contains lead, a hazardous substance
  • Distributed to one customer in New York
  • No reported injuries or incidents

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Details

Model Numbers
Lot: CAM040
Exp. 06/30/2029 Lot: CAL079-N
Exp. 09/30/2028
Affected States
NY
Report Date
February 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more